Donnerstag, 30.05.2019

New LIED publications in 2020

Anti-neonatal Fc Receptor (FcRn) Antibody Treatment Ameliorates Experimental Epidermolysis Bullosa Acquisita in Mice

Freitag, 17.05.2019

GRK1727 Spring Retreat 2020

The Spring Retreat 2020 will take place on April 28th on the campus in Lübeck.

Donnerstag, 21.02.2019

New LIED publications

Kasprick A, Bieber K, Ludwig RJ. Drug Discovery for Pemphigoid Diseases. Curr Protoc Pharmacol. 2019 Feb 20:e55. doi: 10.1002/cpph.55
Koga H, Prost-Squarcioni C, Iwata H, Jonkman MF, Ludwig RJ,...

Mittwoch, 21.11.2018

GRK1727 Autumn Retreat 2019

The Autumn Retreat 2019 is scheduled on November 7 and 8 (Thursday and Friday) and will take place in the Vitalia hotel in Bad Segeberg.

Dienstag, 04.09.2018

New LIED publication:

Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients

Mittwoch, 04.07.2018

LIED researchers together with Allmiral discover novel therapeutic target in EBA

Results published in Frontiers in Immunology: Therapeutic effect of a novel PI3Kδ inhibitor in experimental epidermolysis bullosa acquisita...

Donnerstag, 14.06.2018

New publications

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nat Med. 2018 Apr 10;24(4):526 PMID: 29634689

Low-level mitochondrial heteroplasmy modulates DNA replication, glucose metabolism and...